Literature DB >> 1425802

Long-term low-dose cyclosporin A in steroid dependent nephrotic syndrome of childhood.

T J Neuhaus1, H R Burger, M Klingler, A Fanconi, E P Leumann.   

Abstract

Therapy of steroid-dependent idiopathic nephrotic syndrome is often unsatisfactory. Since 1986 we have treated nine children (six male and three female), aged 3-16 years, with cyclosporin A (CsA) during 2.0-5.2 (median 3.1) years. All had minimal change disease on renal biopsy and had previously received cyclophosphamide. Mean daily dosage of CsA was 4.1 mg/kg (range 2.7-5.8) and mean whole blood trough level was 220 ng/ml (range 141-271). The relapse rate decreased from 3.4/patient year before CsA to 0.55 on CsA. Discontinuation of CsA or reduction below 2 mg/kg daily was always followed by a relapse. The overall relapse rate, including the period with very low-dose CsA, was 0.95/patient year. Four patients required additional low-dose alternate-day prednisone. Repeat renal biopsy showed minimal change disease in eight patients and focal segmental glomerulosclerosis in one; CsA-toxicity was mild in two and moderate in one. The latter was the only patient with slightly reduced glomerular filtration rate. Two boys with delayed puberty spontaneously matured and reached expected final height. We conclude that long-term low-dose CsA is very effective and steroid-sparing. Its use is justified in selected patients, particularly in those with numerous relapses and in male patients before and during puberty, as long as renal function and CsA-toxicity are carefully monitored.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1425802     DOI: 10.1007/bf01959089

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  27 in total

Review 1.  Peritonitis in childhood renal disease.

Authors:  E I Feinstein; R W Chesney; I Zelikovic
Journal:  Am J Nephrol       Date:  1988       Impact factor: 3.754

2.  Cyclosporine treatment of nephrotic syndrome in children.

Authors:  J Brodehl; P F Hoyer; B S Oemar; U Helmchen; K Wonigeit
Journal:  Transplant Proc       Date:  1988-06       Impact factor: 1.066

3.  Cyclosporine A for treatment of nephrotic syndromes.

Authors:  M Brandis; R Burghard; J Leititis; B Zimmerhackl; F Hildebrandt; U Helmchen
Journal:  Transplant Proc       Date:  1988-06       Impact factor: 1.066

Review 4.  Ciclosporin in minimal-change glomerulopathy and in focal segmental glomerular sclerosis.

Authors:  C Ponticelli; E Rivolta
Journal:  Am J Nephrol       Date:  1990       Impact factor: 3.754

5.  Nephrotic syndrome: from toddlers to twenties.

Authors:  M A Lewis; E M Baildom; N Davis; I B Houston; R J Postlethwaite
Journal:  Lancet       Date:  1989-02-04       Impact factor: 79.321

6.  Early identification of frequent relapsers among children with minimal change nephrotic syndrome. A report of the International Study of Kidney Disease in Children.

Authors: 
Journal:  J Pediatr       Date:  1982-10       Impact factor: 4.406

7.  Cyclophosphamide treatment of steroid dependent nephrotic syndrome: comparison of eight week with 12 week course. Report of Arbeitsgemeinschaft für Pädiatrische Nephrologie.

Authors: 
Journal:  Arch Dis Child       Date:  1987-11       Impact factor: 3.791

Review 8.  Mechanism of action of cyclosporin A and rationale for use in nephrotic syndrome.

Authors:  J F Borel
Journal:  Clin Nephrol       Date:  1991       Impact factor: 0.975

9.  Cyclosporin in the treatment of idiopathic nephrotic syndrome in children.

Authors:  P Niaudet; R Habib; M J Tete; N Hinglais; M Broyer
Journal:  Pediatr Nephrol       Date:  1987-10       Impact factor: 3.714

10.  Growth after renal transplantation: an update.

Authors:  G Offner; C Aschendorff; J Brodehl
Journal:  Pediatr Nephrol       Date:  1991-07       Impact factor: 3.714

View more
  10 in total

1.  Impact of the cyclosporine-ketoconazole interaction in children with steroid-dependent idiopathic nephrotic syndrome.

Authors:  Amr El-Husseini; Fathy El-Basuony; Ihab Mahmoud; Ahmed Donia; Hussein Sheashaa; Alaa Sabry; Nabil Hassan; Nagy Sayed-Ahmad; Mohamed Sobh
Journal:  Eur J Clin Pharmacol       Date:  2005-12-23       Impact factor: 2.953

2.  Cyclosporine therapy monitored with abbreviated area under curve in nephrotic syndrome.

Authors:  Stefano Rinaldi; Antonella Sesto; Paola Barsotti; Tullio Faraggiana; Francesco Sera; Gianfranco Rizzoni
Journal:  Pediatr Nephrol       Date:  2004-11-25       Impact factor: 3.714

3.  Cyclosporin A does not affect platelets in children with idiopathic nephrotic syndrome.

Authors:  Marcin Tkaczyk; Zbigniew Baj; Michał Nowicki
Journal:  Pediatr Nephrol       Date:  2004-10-28       Impact factor: 3.714

Review 4.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

5.  Long-term cyclosporin A treatment of minimal-change nephrotic syndrome of childhood.

Authors:  S A Hulton; T J Neuhaus; M J Dillon; T M Barratt
Journal:  Pediatr Nephrol       Date:  1994-08       Impact factor: 3.714

6.  Effect of cyclosporin A on glomerular filtration rate in children with minimal change nephrotic syndrome.

Authors:  S A Hulton; L Jadresic; V Shah; R S Trompeter; M J Dillon; T M Barratt
Journal:  Pediatr Nephrol       Date:  1994-08       Impact factor: 3.714

7.  Cyclosporin A therapy in refractory non-infectious childhood uveitis.

Authors:  D J Kilmartin; J V Forrester; A D Dick
Journal:  Br J Ophthalmol       Date:  1998-07       Impact factor: 4.638

8.  Steroid-resistant, cyclosporine-responsive, relapsing nephrotic syndrome.

Authors:  L C Hymes
Journal:  Pediatr Nephrol       Date:  1995-04       Impact factor: 3.714

9.  Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: medical therapy.

Authors:  Kenji Ishikura; Shinsuke Matsumoto; Mayumi Sako; Kazushi Tsuruga; Koichi Nakanishi; Koichi Kamei; Hiroshi Saito; Shuichiro Fujinaga; Yuko Hamasaki; Hiroko Chikamoto; Yasufumi Ohtsuka; Yasuhiro Komatsu; Toshiyuki Ohta; Takuhito Nagai; Hiroshi Kaito; Shuji Kondo; Yohei Ikezumi; Seiji Tanaka; Yoshitsugu Kaku; Kazumoto Iijima
Journal:  Clin Exp Nephrol       Date:  2015-02       Impact factor: 2.617

10.  Cyclosporine-A-induced nephrotoxicity in children with minimal-change nephrotic syndrome: long-term treatment up to 10 years.

Authors:  Birgitta Kranz; Udo Vester; Rainer Büscher; Anne-Margret Wingen; Peter F Hoyer
Journal:  Pediatr Nephrol       Date:  2008-01-16       Impact factor: 3.714

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.